Home›Companies›Chirality Biosciences

Chirality Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing Oct 29, 2025·Suggest an edit

About Chirality Biosciences

Chirality Biosciences is a private company based in Farmingdale, New York, incorporated in 2023 in Delaware. It has reported $3,105,000 raised in one offering on Form D since October 2025. Its chief executive is Arielle Gabalski.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 17, 2025Oct 29, 2025$3,105,000of $4.1M target9$345KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Chirality Biosciences's Form D filed Oct 29, 2025.

AG
Arielle Gabalski
President & Chief Executive Officer, director
RK
JE
Joanna Eagle
Executive officer

Sources

  1. SECChirality Biosciences, Inc. filing history